Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Jun-22 10:00 PM View:  | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 27-May-22 | Disposition | 87,637 | -- | -- | (100%) 87.64K to 0 | |
| 01-Jun-22 4:00 PM View: | Dilsaver Evelyn S Director | Ortho Clinical Diagnostics ... (OCDX) | 27-May-22 | Disposition | 5,200 | -- | -- | (100%) 5.2K to 0 | |
| 01-Jun-22 4:00 PM View: | Labrum Ronald K Director | Ortho Clinical Diagnostics ... (OCDX) | 27-May-22 | Disposition | 109,985 | -- | -- | (100%) 109.98K to 0 | |
| 01-Jun-22 4:15 PM View: | Yates Robert Clifton Director | Ortho Clinical Diagnostics ... (OCDX) | 27-May-22 | Disposition | 323,880 | -- | -- | (100%) 323.88K to 0 | |
| 01-Jun-22 4:00 PM View: | Mac Mahon Thomas P Director | Ortho Clinical Diagnostics ... (OCDX) | 27-May-22 | Disposition | 79,669 | -- | -- | (100%) 79.67K to 0 | |
| 31-May-22 4:30 PM View: | Carlyle Group L.P. 10% Owner | Ortho Clinical Diagnostics ... (OCDX) | 27-May-22 | Disposition | 118,106,000 | -- | -- | (100%) 118.11M to 0 | |
| 01-Jun-22 4:00 PM View: | Hull Carl Director | Ortho Clinical Diagnostics ... (OCDX) | 27-May-22 | Disposition | 21,011 | -- | -- | (34%) 62.18K to 41.17K | |
| 01-Jun-22 4:16 PM View: | Iskra Michael S. Executive Vice President | Ortho Clinical Diagnostics ... (OCDX) | 27-May-22 | Disposition | 150,000 | -- | -- | (100%) 150.0K to 0 | |
| 01-Jun-22 4:00 PM View: | Perez David Brian Director | Ortho Clinical Diagnostics ... (OCDX) | 27-May-22 | Disposition | 8,576 | -- | -- | (100%) 8.58K to 0 | |
| 01-Jun-22 4:00 PM View: | Bechtel Karen Director | Ortho Clinical Diagnostics ... (OCDX) | 27-May-22 | Disposition | 5,200 | -- | -- | (100%) 5.2K to 0 | |
| 01-Jun-22 4:15 PM View: | Smith Christopher M Chairman and CEO Director | Ortho Clinical Diagnostics ... (OCDX) | 27-May-22 | Disposition | 367,360 | -- | -- | (100%) 367.36K to 0 | |
| 01-Jun-22 4:00 PM View: | Hull Carl Director | Ortho Clinical Diagnostics ... (OCDX) | 27-May-22 | Disposition | 41,172 | -- | -- | (100%) 41.17K to 0 | |
| 01-Jun-22 4:00 PM View: | Mac Mahon Thomas P Director | Ortho Clinical Diagnostics ... (OCDX) | 27-May-22 | Disposition | 62,184 | -- | -- | (44%) 141.85K to 79.67K | |
| 06-Apr-22 4:05 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 04-Apr-22 | Planned Option Sale | 88,043 | $18.77 | $1,652,240.00 | (50%) 175.68K to 87.64K | |
| 06-Apr-22 4:05 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 04-Apr-22 | Option Exercise | 88,043 | $6.28 | $552,910.00 | 100% 87.64K to 175.68K | |
| 04-Apr-22 4:05 PM View: | Yates Robert Clifton Director | Ortho Clinical Diagnostics ... (OCDX) | 31-Mar-22 | Payment of Exercise | 214 | $18.66 | $3,993.24 | (5%) 4.43K to 4.22K | |
| 05-Jan-22 4:23 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 03-Jan-22 | Planned Option Sale | 130,000 | $21.09 | $2,741,620.00 | (60%) 217.64K to 87.64K | |
| 05-Jan-22 4:23 PM View: | Smith Christopher M Chairman and CEO Director | Ortho Clinical Diagnostics ... (OCDX) | 03-Jan-22 | Option Exercise | 100,000 | $12.56 | $1,256,000.00 | 27% 367.36K to 467.36K | |
| 05-Jan-22 4:24 PM View: | Yates Robert Clifton Director | Ortho Clinical Diagnostics ... (OCDX) | 03-Jan-22 | Payment of Exercise | 214 | $21.12 | $4,519.68 | (5%) 4.65K to 4.43K | |
| 05-Jan-22 4:23 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 03-Jan-22 | Option Exercise | 130,000 | $6.28 | $816,400.00 | 148% 87.64K to 217.64K | |
| 05-Jan-22 4:23 PM View: | Smith Christopher M Chairman and CEO Director | Ortho Clinical Diagnostics ... (OCDX) | 03-Jan-22 | Planned Option Sale | 100,000 | $21.10 | $2,109,800.00 | (21%) 467.36K to 367.36K | |
| 17-Dec-21 7:28 PM View: | Mac Mahon Thomas P Director | Ortho Clinical Diagnostics ... (OCDX) | 14-Dec-21 | Gift | 79,669 | -- | -- | 56% 141.85K to 221.52K | |
| 17-Dec-21 7:28 PM View: | Mac Mahon Thomas P Director | Ortho Clinical Diagnostics ... (OCDX) | 14-Dec-21 | Gift | 79,669 | -- | -- | (36%) 221.52K to 141.85K | |
| 19-Oct-21 4:15 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 15-Oct-21 | Option Exercise | 75,464 | $6.28 | $473,914.00 | 86% 87.64K to 163.1K | |
| 19-Oct-21 4:15 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 15-Oct-21 | Planned Option Sale | 75,464 | $19.73 | $1,489,010.00 | (46%) 163.1K to 87.64K | |
| 04-Oct-21 4:13 PM View: | Yates Robert Clifton Director | Ortho Clinical Diagnostics ... (OCDX) | 30-Sep-21 | Payment of Exercise | 277 | $18.48 | $5,118.96 | (6%) 4.92K to 4.65K | |
| 16-Sep-21 4:30 PM View: | Carlyle Group L.P. 10% Owner | Ortho Clinical Diagnostics ... (OCDX) | 14-Sep-21 | Sale | 25,300,000 | $16.80 | $425,040,000.00 | (18%) 143.41M to 118.11M | |
| 18-Aug-21 5:41 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 18-Aug-21 | Planned Option Sale | 41,015 | $20.14 | $826,013.00 | (32%) 128.65K to 87.64K | |
| 18-Aug-21 5:41 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 18-Aug-21 | Option Exercise | 41,015 | $6.28 | $257,574.00 | 47% 87.64K to 128.65K | |
| 18-Aug-21 5:41 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 16-Aug-21 | Planned Option Sale | 4,000 | $20.03 | $80,110.40 | (4%) 91.64K to 87.64K | |
| 18-Aug-21 5:41 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 16-Aug-21 | Option Exercise | 4,000 | $6.28 | $25,120.00 | 5% 87.64K to 91.64K | |
| 13-Aug-21 5:22 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 13-Aug-21 | Option Exercise | 4,300 | $6.28 | $27,004.00 | 5% 87.64K to 91.94K | |
| 13-Aug-21 5:22 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 13-Aug-21 | Planned Option Sale | 4,300 | $20.00 | $86,003.00 | (5%) 91.94K to 87.64K | |
| 13-Aug-21 5:22 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 12-Aug-21 | Planned Option Sale | 8,100 | $20.00 | $162,003.00 | (8%) 95.74K to 87.64K | |
| 13-Aug-21 5:22 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 12-Aug-21 | Option Exercise | 8,100 | $6.28 | $50,868.00 | 9% 87.64K to 95.74K | |
| 13-Aug-21 5:22 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 11-Aug-21 | Planned Option Sale | 72,585 | $19.76 | $1,434,620.00 | (45%) 160.22K to 87.64K | |
| 13-Aug-21 5:22 PM View: | Schlesinger Michael A. EVP, GC and Secretary | Ortho Clinical Diagnostics ... (OCDX) | 11-Aug-21 | Option Exercise | 72,585 | $6.28 | $455,834.00 | 83% 87.64K to 160.22K | |
| 04-Oct-21 4:13 PM View: | Yates Robert Clifton Director | Ortho Clinical Diagnostics ... (OCDX) | 05-Aug-21 | Payment of Exercise | 277 | $20.69 | $5,731.13 | (5%) 5.2K to 4.92K | |
| 04-Aug-21 6:29 PM View: | Smith Christopher M Chairman and CEO Director | Ortho Clinical Diagnostics ... (OCDX) | 04-Aug-21 | Sale (Planned) | 61,800 | $21.79 | $1,346,620.00 | (14%) 429.16K to 367.36K | |
| 04-Aug-21 6:29 PM View: | Yates Robert Clifton Director | Ortho Clinical Diagnostics ... (OCDX) | 04-Aug-21 | Sale (Planned) | 140,042 | $21.79 | $3,051,520.00 | (96%) 145.24K to 5.2K | |
| 04-Aug-21 6:29 PM View: | Yates Robert Clifton Director | Ortho Clinical Diagnostics ... (OCDX) | 03-Aug-21 | Sale (Planned) | 176,149 | $21.59 | $3,803,110.00 | (55%) 321.39K to 145.24K | |
| 04-Aug-21 6:29 PM View: | Smith Christopher M Chairman and CEO Director | Ortho Clinical Diagnostics ... (OCDX) | 03-Aug-21 | Sale (Planned) | 104,987 | $21.55 | $2,262,830.00 | (20%) 534.15K to 429.16K | |
| 04-Aug-21 6:29 PM View: | Yates Robert Clifton Director | Ortho Clinical Diagnostics ... (OCDX) | 02-Aug-21 | Planned Option Sale | 23,062 | $22.06 | $508,734.00 | (7%) 346.94K to 323.88K | |
| 04-Aug-21 6:29 PM View: | Smith Christopher M Chairman and CEO Director | Ortho Clinical Diagnostics ... (OCDX) | 02-Aug-21 | Sale (Planned) | 103,213 | $22.10 | $2,281,040.00 | (16%) 637.36K to 534.15K | |
| 04-Aug-21 6:29 PM View: | Yates Robert Clifton Director | Ortho Clinical Diagnostics ... (OCDX) | 02-Aug-21 | Sale (Planned) | 2,489 | $22.06 | $54,905.80 | (< 1%) 323.88K to 321.39K | |
| 04-Aug-21 6:29 PM View: | Yates Robert Clifton Director | Ortho Clinical Diagnostics ... (OCDX) | 02-Aug-21 | Option Exercise | 23,062 | $6.28 | $144,829.00 | 7% 323.88K to 346.94K | |
| 25-May-21 4:15 PM View: | Iskra Michael S. Executive Vice President | Ortho Clinical Diagnostics ... (OCDX) | 21-May-21 | Grant | 150,000 | -- | -- | 100% 0 to 150.0K | |
| 05-May-21 5:00 PM View: | Hull Carl Director | Ortho Clinical Diagnostics ... (OCDX) | 03-May-21 | Grant | 2,600 | -- | -- | 4% 59.58K to 62.18K | |
| 05-May-21 5:00 PM View: | Perez David Brian Director | Ortho Clinical Diagnostics ... (OCDX) | 03-May-21 | Grant | 2,600 | -- | -- | 44% 5.98K to 8.58K | |
| 05-May-21 5:00 PM View: | Bechtel Karen Director | Ortho Clinical Diagnostics ... (OCDX) | 03-May-21 | Grant | 5,200 | -- | -- | 100% 0 to 5.2K |
